Dr. T. (Teo) Forcht Dagi is a neurosurgeon who serves as a distinguished scholar and professor at Queen’s University Belfast, Northern Ireland. He chaired the international advisory panel for the medical school until 2017 and currently chairs the panel for the school of management. He chaired the Council on Perioperative Care of the American College of Surgeons and the Council on Surgical and Perioperative Safety, and served as a Director of the American Association of Neurological Surgeons. He has served as a consultant on medical technologies to the Office of Technology Assessment of the Congress of the United States, and on neurological drugs and devices to the US Food and Drug Administration. He is an editor of Neurosurgery and the Journal of Clinical Ethics. He trained at the Massachusetts General Hospital and served as a neurosurgeon and flight surgeon in the US Army Medical Corps (Reserve).
Dr. Dagi has also been active as a venture capitalist and an entrepreneur in the medical device arena. He has actively managed two investment funds and served as an advisor to industry organizations, investment banks, conventional venture capital organizations and venture philanthropies. He taught in and directed the Harvard-MIT Program in biomedical entrepreneurship and sits on the Board of the Medical Development Group (Boston) and several medical device and biopharma companies. He serves as the CEO of Boston Neurosciences, a non-invasive neuro-monitoring company focused on intracranial pressure and cerebral autoregulation.